🔥🐔 BizChicken 🐔🔥
Companies Similar to Aerovate Therapeutics, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Athira Pharma, Inc.
ATH-1017
Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, with its lead product, ATH-1017, in clinical trials for Alzheimer's and Parkinson's diseases.
Symbol: ATHA
Recent Price: $0.55
Industry: Biotechnology
CEO: Dr. Mark J. Litton M.B.A., Ph.D.
Sector: Healthcare
Employees: 65
Address: 18706 North Creek Parkway, Bothell, WA 98011
Phone: 425 620 8501
Last updated: 2024-12-31
Applied Therapeutics, Inc.
AT-007
Applied Therapeutics, Inc., a biopharmaceutical company, develops novel products targeting cardiovascular disease, galactosemia, and diabetic complications. Key products include AT-007 and AT-001.
About | Leadership | Leadership | Leadership | Leadership | Vision/Values | Culture | DEI | Contact | Contact | Careers | Careers | About | About | About
Symbol: APLT
Recent Price: $0.81
Industry: Biotechnology
CEO: Dr. Shoshana Shendelman Ph.D.
Sector: Healthcare
Employees: 31
Address: 545 Fifth Avenue, New York, NY 10017
Phone: 212 220 9226
Leadership
- Shoshana Shendelman, Chair, Board of Directors
- Riccardo Perfetti, Chief Medical Officer
- Les Funtleyder,
- Dale Hooks, Chief Commercial Officer
- Constantine Chinoporos, Chief Business Officer / Chief Operating Officer
- Joel Marcus,
- Jay Skyler,
- Stacy Kanter,
- Teena Lerner,
- Donald Landry M.D., Ph.D., Chair, Scientific Advisory Board
- Roy Freeman M.D.,
- Roxana Mehran M.D.,
- Lawrence Steinman M.D.,
- Gregg Stone M.D.,
- Donald d'Amico M.D.,
- Donald Landry, Chair, Scientific Advisory Board
- Roy Freeman,
- Roxana Mehran,
- Lawrence Steinman,
- Gregg Stone,
- Donald d'Amico,
Last updated: 2024-12-31
Atea Pharmaceuticals, Inc.
AT-527
Atea Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics for viral infections, with a lead product candidate AT-527 for COVID-19 treatment.
Symbol: AVIR
Recent Price: $3.33
Industry: Biotechnology
CEO: Dr. Jean-Pierre Sommadossi Ph.D.
Sector: Healthcare
Employees: 75
Address: 125 Summer Street, Boston, MA 02110
Phone: 857 284 8891
Leadership
- Jean-Pierre Sommadossi, PhD, FOUNDER, CHAIRMAN & CEO
- Nancy Agrawal, PhD, Executive VP, Preclinical Development
- Jonae Barnes, Senior VP, Investor Relations & Corporate Communications
- Bruce Belanger, PhD, Senior VP, Biostatistics
- Andrea Corcoran, CFO & Executive VP, Legal
- Adam DeZure, MD, VP, Clinical Development
- James MB Evans, PhD, VP, CMC Manufacturing
- Wayne Foster, EXECUTIVE VP, Chief Accounting Officer
- Kerry Gagnon, VP, Head of Quality
- Steven Good, EXECUTIVE VP, PRECLINICAL SCIENCE
- Janet Hammond, MD, PhD, CHIEF DEVELOPMENT OFFICER
- Arantxa Horga, MD, Chief Medical Officer
- Qi Huang, Senior VP, Virology
- Laura Ishak, Senior VP, Clinical Operations
- Ariyapadi Krishnaraj, VP, Marketing
- Adel Moussa, PhD, EXECUTIVE VP, CHEMISTRY
- Shari Noble, VP, Deputy General Counsel
- Keith Pietropaolo, Executive VP, Clinical Sciences and Project Management
- Brian Rowe, VP, Business Development
- Marc Van Hulle, VP, Finance
- John Vavricka, CHIEF COMMERCIAL OFFICER
- Alex Vo, PhD, VP, DMPK
- Jayanthi Wolf, PhD, Executive VP, Regulatory Affairs
- Xiao-Jian Zhou, PhD, EXECUTIVE VP, EARLY STAGE DEVELOPMENT
Last updated: 2024-12-31
Tenax Therapeutics, Inc.
TNX-103, TNX-102 (levosimendan), TNX-201 (imatinib)
Tenax Therapeutics, Inc. is a specialty pharmaceutical company that focuses on identifying, developing, and commercializing products for cardiovascular and pulmonary diseases. The company is involved in developing medications such as TNX-103 and TNX-102 (levosimendan) for pulmonary hypertension and heart failure, and TNX-201 (imatinib) for pulmonary arterial hypertension.
Symbol: TENX
Recent Price: $6.55
Industry: Biotechnology
CEO: Mr. Christopher T. Giordano
Sector: Healthcare
Employees: 5
Address: ONE Copley Parkway, Morrisville, NC 27560
Phone: 919 855 2100
Last updated: 2024-12-31
Aileron Therapeutics, Inc.
ALRN-6924
Aileron Therapeutics, Inc. is a clinical stage oncology company developing ALRN-6924 for various cancer treatments, with multiple clinical trials in progress.
Symbol: ALRN
Recent Price: $2.32
Industry: Biotechnology
CEO: Dr. James Brian Windsor Ph.D.
Sector: Healthcare
Employees: 15
Address: 285 Summer Street, Boston, MA 02210
Phone: 617 995 0900
Last updated: 2024-12-31
Aerovate Therapeutics, Inc.
AV-101
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing drugs for rare cardiopulmonary diseases, with a lead product AV-101 for pulmonary arterial hypertension.
Symbol: AVTE
Recent Price: $2.66
Industry: Biotechnology
CEO: Mr. Timothy P. Noyes M.B.A.
Sector: Healthcare
Employees: 51
Address: 930 Winter Street, Waltham, MA 02116
Phone: 617 443 2400
Last updated: 2024-12-31
Avalo Therapeutics, Inc.
AVTX-002, AVTX-007, AVTX-801
Avalo Therapeutics, Inc. is a clinical-stage precision medicine company focused on discovering, developing, and commercializing targeted therapeutics for patients with unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases.
Symbol: AVTX
Recent Price: $7.80
Industry: Biotechnology
CEO: Dr. Garry A. Neil M.D.
Sector: Healthcare
Employees: 19
Address: 540 Gaither Road, Rockville, MD 20850
Phone: 410 522 8707
Leadership
- Garry A. Neil, MD, Chairman of the Board and Chief Executive Officer
- Mittie Doyle, MD, FACR, Chief Medical Officer
- Chris Sullivan, Chief Financial Officer
- Paul Varki, Chief Legal Officer
- Lisa Hegg PhD, Senior Vice President, Program Management and Corporate Infrastructure and Clinical Operations
- Colleen Matkowski, Senior Vice President, Global Regulatory Affairs and Quality Assurance
- Dino C. Miano, PhD, Senior Vice President, CMC and Technical Operations
- June Almenoff, MD, PhD, President and Chief Medical Officer
- Mitchell Chan, Chief Financial Officer
- Jonathan Goldman, MD, CEO
- Aaron Kantoff, Managing Partner
- Gilla Kaplan, PhD, Independent Director
- Samantha Truex, CEO
Last updated: 2024-12-31
Anavex Life Sciences Corp.
ANAVEX 2-73
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company developing drug candidates for CNS diseases, including Alzheimer's, Rett syndrome, and Parkinson's.
Symbol: AVXL
Recent Price: $11.04
Industry: Biotechnology
CEO: Dr. Christopher U. Missling M.B.A., M.S., Ph.D.
Sector: Healthcare
Employees: 40
Address: 51 West 52nd Street, New York, NY 10019
Phone: 844 689 3939
Last updated: 2024-12-31
Blueprint Medicines Corporation
AYVAKIT, BLU-263, Fisogatinib, GAVRETO, BLU-701, BLU-945, BLU-451, BLU-782
Blueprint Medicines Corporation is a precision therapy company focused on developing medicines for genomically defined cancers and blood disorders, including treatment for systemic mastocytosis, gastrointestinal stromal tumors, hepatocellular carcinoma, and non-small-cell lung carcinoma.
About | About | Vision/Values | About | About | About | About | Contact | Contact | Careers | Careers | Careers | Careers | Careers | About | About | About | About | About | About | About | About | About | About | About | About | About | About | Careers | Vision/Values | About | About
Symbol: BPMC
Recent Price: $86.82
Industry: Biotechnology
CEO: Ms. Kathryn Haviland M.B.A.
Sector: Healthcare
Employees: 638
Address: 45 Sidney Street, Cambridge, MA 02139
Phone: 617 374 7580
Last updated: 2024-12-31
4D Molecular Therapeutics, Inc.
4D-125, 4D-110, 4D-310, 4D-150, 4D-710
4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company developing product candidates using adeno-associated virus vectors, focusing on ophthalmology, cardiology, and pulmonology.
About | About | Contact | News | News | News | Careers | Careers | About | DEI | Careers | Leadership | Careers | Careers
Symbol: FDMT
Recent Price: $5.30
Industry: Biotechnology
CEO: Dr. David H. Kirn M.D.
Sector: Healthcare
Employees: 201
Address: 5858 Horton Street, EmeryVille, CA 94608
Phone: 510 505 2680
Last updated: 2024-12-31
Ovid Therapeutics Inc.
OV101, OV329, OV350, OV882, OV815
Ovid Therapeutics Inc., a biopharmaceutical company based in New York, is dedicated to developing impactful medicines for neurological disorders. They have a range of drug candidates like OV101 and are involved in various clinical trials.
Our Story | Leadership | Directors | About | Our Story | Contact | About | About | About | About | About | Culture | Culture | Vision/Values | Culture | About | Culture | Culture | About | Jobs | Careers | Careers | Jobs | About | About | About | Careers | Vision/Values | About | About | About | About | About | About
Symbol: OVID
Recent Price: $0.96
Industry: Biotechnology
CEO: Dr. Jeremy Max Levin Ba Zoology, Dphil, M.D., Mb Bchir, Ph.D.
Sector: Healthcare
Employees: 40
Address: 1460 Broadway, New York, NY 10036
Phone: 646 661 7661
Leadership
- Jeremy M. Levin, D.Phil, MB BChir, Chief Executive Officer and Chairman
- Meg Alexander, President and Chief Operating Officer
- Zhong Zhong, Ph.D., Chief Scientific Officer
- Jeffrey Rona, Chief Business and Financial Officer
- Amanda Banks, M.D., Chief Development Officer
- Julia Tsai, Ph.D., Senior Vice President of Clinical Development
- Karen Bernstein, Ph.D., Director, Chair of the Compensation Committee, Member of the Audit and Nominating and Corporate Governance Committees
- Barbara G. Duncan, MBA, Director, Chair of the Audit Committee, Member of the Nominating and Corporate Governance Committee
- Bart Friedman, J.D., Lead Independent Director, Chair of the Nominating and Corporate Governance Committee, Member of the Audit and Compensation Committees
- Michael Poole, M.D., FACP, Director, Member of the Audit and Compensation Committees
- Kevin Fitzgerald, Ph.D., Director, Member of the Nominating and Corporate Governance Committee
Last updated: 2024-12-31
Vaxcyte, Inc.
VAX-24
Vaxcyte, Inc. is a clinical-stage biotechnology company developing novel protein vaccines for preventing or treating bacterial infectious diseases. Key products include the VAX-24 pneumococcal conjugate vaccine and other candidates targeting antibiotic resistance and periodontitis.
Symbol: PCVX
Recent Price: $81.99
Industry: Biotechnology
CEO: Mr. Grant E. Pickering M.B.A.
Sector: Healthcare
Employees: 254
Address: 825 Industrial Road, San Carlos, CA 94070
Phone: 650 837 0111
Last updated: 2024-12-31
Rocket Pharmaceuticals, Inc.
Gene Therapies
Rocket Pharmaceuticals, Inc. is a biotechnology company focused on developing gene therapies for rare and devastating diseases, with multiple clinical-stage programs targeting disorders such as fanconi anemia, leukocyte adhesion deficiency-I, pyruvate kinase deficiency, and Danon disease.
Symbol: RCKT
Recent Price: $12.03
Industry: Biotechnology
CEO: Dr. Gaurav D. Shah M.D.
Sector: Healthcare
Employees: 268
Address: 9 Cedarbrook Drive, Cranbury, NJ 08512
Phone: 609 659 8001
Last updated: 2024-12-31
Verve Therapeutics, Inc.
VERVE-101
Verve Therapeutics, Inc. is a genetic medicines company developing gene editing treatments for cardiovascular diseases, primarily through its lead product VERVE-101.
Symbol: VERV
Recent Price: $5.54
Industry: Biotechnology
CEO: Dr. Sekar Kathiresan M.D.
Sector: Healthcare
Employees: 255
Address: 500 Technology Square, Cambridge, MA 02139
Phone: 617 603 0070
Leadership
- Andrew Ashe, President, Chief Operating Officer and General Counsel
- Victoria Bartlett, Vice President, Program and Alliance Management
- Dan Balian, Associate Director, Supply Chain Management
- Allen Barrett, Director, Corporate Counsel
Last updated: 2024-12-31
X4 Pharmaceuticals, Inc.
mavorixafor
X4 Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company dedicated to the development and commercialization of novel therapeutics for rare diseases, with its lead product mavorixafor in advanced clinical trials.
Symbol: XFOR
Recent Price: $0.81
Industry: Biotechnology
CEO: Dr. Paula Ragan Ph.D.
Sector: Healthcare
Employees: 127
Address: 61 North Beacon Street, Boston, MA 02134
Phone: 857 529 8300
Last updated: 2024-12-31
Aviat Networks, Inc.
Wireless transport solutions
Aviat Networks, Inc. provides wireless transport solutions worldwide, offering products and services for simplifying networks with applications in microwave and millimeter wave networking.
About | About | About | About | Contact | Contact | Contact | Contact | Contact | Contact | Contact | Contact | Contact | Contact | Contact | Contact | Contact | Contact | Contact | Contact | About | About | About | About
Symbol: AVNW
Recent Price: $17.49
Industry: Communication Equipment
CEO: Mr. Peter A. Smith Ph.D.
Sector: Technology
Employees: 909
Address: 200 Parker Drive, Austin, TX 78728
Phone: 408 941 7100
Last updated: 2024-12-31
Avenue Therapeutics, Inc.
intravenous Tramadol
Avenue Therapeutics, Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the acute/intensive care hospital setting. The company is advancing intravenous Tramadol, a synthetic dual-acting opioid, in Phase III clinical trials for post-operative acute pain treatment.
About | Leadership | Directors | About | Leadership | About | Contact | About | Contact | Contact | Careers | Leadership | Directors | About | About | Contact | About
Symbol: ATXI
Recent Price: $1.94
Industry: Biotechnology
CEO: Dr. Alexandra MacLean M.D.
Sector: Healthcare
Employees: 3
Address: 1140 Avenue of the America, New York, NY 10036
Phone: 781 652 4500
Leadership
- Jay Kranzler, MD, PhD, Chairman of the Board of Directors
- Alexandra MacLean, MD, Director
- David Jin, Interim Chief Financial Officer
- Scott A. Reines, MD, PhD, Interim Chief Medical Officer
- Michael Ryan, MS, Vice President of Clinical Operations and Program Management
- Alix MacLean, Chief Executive Officer
- Lindsay A. Rosenwald, MD, Director
- Neil Herskowitz, Director
- Curtis Oltmans, Director
- Faith Charles, Director
Last updated: 2024-12-31
Aptevo Therapeutics Inc.
APVO436
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company specializing in the development of immunotherapeutic candidates to treat various forms of cancer, with a primary focus on APVO436, a bispecific T-cell engaging antibody for leukemia and myelodysplastic syndrome.
About | Leadership | Directors | About | Contact | About | Contact | Contact | Contact | About | Leadership | Directors | About | About | About | About | About | About | About | About | About | About | About
Symbol: APVO
Recent Price: $4.78
Industry: Biotechnology
CEO: Mr. Marvin L. White
Sector: Healthcare
Employees: 40
Address: 2401 4th Avenue, Seattle, WA 98121
Phone: 206 838 0500
Leadership
- Marvin L. White, President and Chief Executive Officer
- Jeff Lamothe, EVP and Chief Operating Officer
- Daphne Taylor, SVP and Chief Financial Officer
- Dirk Huebner, M.D., Chief Medical Officer
- SoYoung Kwon, SVP, General Counsel, Business Development and Corporate Affairs
Last updated: 2024-12-31
PaxMedica, Inc. Common Stock
PAX-101
Pax Medica, Inc., is a clinical stage biopharmaceutical company focused on developing anti-purinergic drug therapies for treating intractable neurologic disorders. Their lead product, PAX-101, is an intravenous formulation of suramin for indications such as autism spectrum disorder and chronic fatigue syndrome.
Symbol: PXMD
Recent Price: $0.06
Industry: Biotechnology
CEO: Mr. Howard J. Weisman
Sector: Healthcare
Employees: 6
Address: 303 South Broadway, Tarrytown, NY 10591
Phone: 914-987-2876
Last updated: 2024-12-31
Terns Pharmaceuticals, Inc.
TERN-101, TERN-201, TERN-501, TERN-601
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for non-alcoholic steatohepatitis (NASH) and obesity, incorporating products like TERN-101, TERN-201, TERN-501, and TERN-601.
About | Contact | Careers | Careers | Careers | About | About | Careers | Culture | About | Leadership | About
Symbol: TERN
Recent Price: $7.15
Industry: Biotechnology
CEO: Ms. Amy L. Burroughs M.B.A.
Sector: Healthcare
Employees: 66
Address: 1065 East Hillsdale Boulevard, Foster City, CA 94404
Phone: 650 525 5535
Last updated: 2024-11-08